Early and long term coronary artery bypass grafting outcomes in patients under 45 years of age

Kardiologia Polska

Volumn 71, Issue 1, 2013, Pages 32-39

  Zwoliski, Radosaw ^a   Jander, Sawomir ^a   Ostrowski, Stanisaw ^a   Bartczak, Karol ^a   AdamekKomider, Anna ^a   Bany, Andrzej ^a   Jaszewski, Ryszard ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Age under 45 years; Coronary artery bypass grafting; Early and long term outcomes

Indexed keywords

ADULT; AGE DISTRIBUTION; ANGINA PECTORIS; ARTICLE; BLEEDING; BRAIN ISCHEMIA; CORONARY ARTERY BYPASS GRAFT; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; FORWARD HEART FAILURE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEMATOTHORAX; HUMAN; INTRAAORTIC BALLOON PUMP; ISCHEMIC HEART DISEASE; LEG AMPUTATION; MAJOR CLINICAL STUDY; MALE; OCCUPATION; OUTCOME ASSESSMENT; PNEUMOTHORAX; POSTOPERATIVE PERIOD; RECURRENT DISEASE; REOPERATION; REPEAT PROCEDURE; RESPIRATORY FAILURE; RISK FACTOR; SEX DIFFERENCE; SURGICAL MORTALITY; SURVIVAL RATE;

EID: 84872942746     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Meinert CL, Gilipin AK, Unalp A, Dawson C. Gender representation in trials. Control Clin Trials, 2000; 21: 462-475.
2. Vaccarino V, Abramson JL, Veledar E, Weintraub W. Sex differences in hospital mortality after coronary artery bypass surgery. Evidence for a higher mortality in younger women. Circulation, 2002; 105: 1176-1181.
3. Regitz-Zagrosek V, Lehmkuhl E, Hocher B et al. Gender as a risk factor, not in old, women undergoing coronary artery bypass grafting. J Am Coll Cardiol, 2004; 44: 2413-2414.
4. Enas AE. Lipoprotein(a) as a determinant of coronary heart disease in young women: a stronger risk factor than diabetes (to the editor). Circulation, 1998; 27: 293-295.
5. Gardner TJ, Horneffer PJ, Gott VL et al. Coronary artery bypass grafting in women: a ten- year perspective. Ann Surg, 1985; 201: 780-784.
6. Hogue CW Jr, Barzilai B, Pieper KS et al. Sex differences in neurological outcomes and mortality after cardiac surgery. A Society of Thoracic Surgery National Database report. Circulation, 2001; 103: 2133-2137.
7. Humphries KH, Gao M, Pu A et al. Significant improvement in short-term mortality in women undergoing coronary artery bypass surgery (1991-2004). J Am Coll Cordiol, 2007; 49: 1552-1558.
8. Zwoliski R, Jander S, Jegier B et al. Obraz kliniczny i powikania pooperacyjne u chorych poddanych chirurgicznej rewaskularyzacji minia sercowego do 45 roku ycia. Pol Przegl Kardiol, 2002; 4: 349-354.
9. Herlitz J, Brandrup-Wognsen G, Karlson BW et al. Mortality, risk indicators of death, mode of death and symptoms of angina pectoris during 5 years after coronary artery bypass grafting in men and women. J Intern Med, 2000; 247: 500-506.
10. Di Carli MF, Afonso L, Campisi R et al. Coronary vascular dysfunction in premenopausal women with diabetes mellitus. Am Heart J, 2002; 144: 711-718.
11. Steinberg HO, Paradisi G, Cronic J et al. Type II abrogates sex differences in endothelial function in premenopausal women. Circulation, 2000; 101: 2040-2046.
12. Sowiska-Srzednicka J, Malczewska B, Srzednicki M et al. Hyperinsulinaemia and decreased plasma levels of dehydroepiandrosterone sulfate in premenopausal women with coronary heart disease. J Intern Med, 1995; 237: 465-472.
13. Croft P, Hannaford PC. Risk factors for acute myocardial infarction: evidence from the Royal College of General Practitioners' oral contraception study. BMJ, 1989; 298: 165-168.
14. Zwoliski R, Ostrowski S, Walczak A et al. Long-term results of coronary artery bypass grafting in women under 45 years of age. Kardiochir Torakochir Pol, 2012; 1: 22-27.
15. Hu FB, Grodstein F, Hennekens CH et al. Age at natural menopause an risk of cardiovascular disease. Arch Intern Med, 1999; 159: 1061-1066.
16. Colditz GA, Willett WC, Stampfer MJ. Menopause and risk of coronary heart disease in women. N Engl J Med, 1987; 316: 1105-1110.
17. Carmina E, Lobo RA. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab, 1999; 84: 1897-1899.
18. Ehrmann DA, Barnes RB, Rosenfield RL et al. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care, 1999; 22: 141-146.
19. Dahlgren E, Janson PO, Johansson S et al. Polycystic ovary syndrome and risk for myocardial infarction: evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand, 1992; 71: 599-604.
20. Losordo DW, Kearney M, Kim EA et al. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation, 1994; 89: 1501-1510.
21. Kortelainen ML, Huttunen P. Expression of estrogen receptors in the coronary arteries of young and premenopausal women in relation to central obesity. Int J Obes Relat Metab Disord, 2004; 28: 623-627.
22. Shearman AM, Cupples LA, Demissie S. Association between estrogen alpha gene variation and cardiovascular disease. JAMA, 2003; 5: 2263-2270.
23. Nishida H, Nakajima M, Ihashi K et al. Effects of smaller physical size on complex arterial grafting in coronary artery operations. Ann Thorac Surg, 1996; 62: 733-736.
24. Ramstrom J, Lund O, Cadavid E et al. Multiarterial coronary artery bypass grafting with special reference to small vessel disease and results in women. Eur Heart J, 1993; 14: 634-639.
25. Loop FD, Golding LR, MacMillan JP et al. Coronary artery surgery in women compared with men: analyses of risks and long-term results. J Am Coll Cardiol, 1983; 1: 383-390.
26. Sheifer SE, Canos MR, Weinfurt KP et al. Sex differences in coronary artery size assessed by intravascular ultrasound. Am Heart J, 2000; 139: 649-653.